Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Cannon

Showing results (61-70 of 858) with videos related to

Pageof 86
Sort By:
Critical Pathways in Cardiology|October 13, 2011
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolismSubroto Acharjee, Christopher P Cannon
Lancet (London, England)|November 26, 2011
Statins and safety: can we finally be reassured?Payal Kohli, Christopher P Cannon
Reviews in Cardiovascular Medicine|August 12, 2010
News and views from the literature. Antiplatelet therapy. Ticagrelor in acute coronary syndrome: a new frontier in platelet inhibitionAmit Kumar, Christopher P Cannon
Clinical Cornerstone|October 1, 2009
Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical optionsChristopher P Cannon, Amit Kumar
Journal of the American College of Cardiology|August 18, 2012
Danger ahead: watch out for indirect comparisons!Christopher P Cannon, Payal Kohli
Reviews in Cardiovascular Medicine|November 10, 2009
Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelinesChristopher P Cannon, Salman Waheed
Current Cardiology Reports|May 27, 2018
Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular EventsSara Lee, Christopher P Cannon
European Heart Journal|April 18, 2012
A new approach to managing the 'statin-intolerant' patient?Payal Kohli, Christopher P Cannon
Mayo Clinic Proceedings|November 3, 2009
Acute coronary syndromes: Diagnosis and management, part IIAmit Kumar, Christopher P Cannon
JACC. Cardiovascular Interventions|October 25, 2023
Ticagrelor-Induced Dyspnea: A Controllable Side EffectGwangsil Kim, Christopher P Cannon
Pageof 86

Showing results (61-70 of 858) with videos related to

Sort By:
Pageof 86
Critical Pathways in Cardiology|October 13, 2011
Dabigatran: a new option for anticoagulation in atrial fibrillation and venous thromboembolismSubroto Acharjee, Christopher P Cannon
Lancet (London, England)|November 26, 2011
Statins and safety: can we finally be reassured?Payal Kohli, Christopher P Cannon
Reviews in Cardiovascular Medicine|August 12, 2010
News and views from the literature. Antiplatelet therapy. Ticagrelor in acute coronary syndrome: a new frontier in platelet inhibitionAmit Kumar, Christopher P Cannon
Clinical Cornerstone|October 1, 2009
Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical optionsChristopher P Cannon, Amit Kumar
Journal of the American College of Cardiology|August 18, 2012
Danger ahead: watch out for indirect comparisons!Christopher P Cannon, Payal Kohli
Reviews in Cardiovascular Medicine|November 10, 2009
Evaluating medical, percutaneous coronary intervention, and coronary artery bypass surgery options for chronic angina: an update of the revised guidelinesChristopher P Cannon, Salman Waheed
Current Cardiology Reports|May 27, 2018
Combination Lipid-Lowering Therapies for the Prevention of Recurrent Cardiovascular EventsSara Lee, Christopher P Cannon
European Heart Journal|April 18, 2012
A new approach to managing the 'statin-intolerant' patient?Payal Kohli, Christopher P Cannon
Mayo Clinic Proceedings|November 3, 2009
Acute coronary syndromes: Diagnosis and management, part IIAmit Kumar, Christopher P Cannon
JACC. Cardiovascular Interventions|October 25, 2023
Ticagrelor-Induced Dyspnea: A Controllable Side EffectGwangsil Kim, Christopher P Cannon
Pageof 86